Karelizumab for Injection is currently priced at 2,928 yuan a bottle before medical insurance reimbursement, and individuals need to pay about 1,000 yuan to 1,200 yuan out of pocket due to different reimbursement ratios around the world. The common specification of this drug is 200mg/bottle, and its price is affected by the reimbursement ratio of medical insurance, and the specific cost has some differences. This product has entered the medical insurance, the cost of a bottle of 2928 yuan before reimbursement, medical insurance reimbursement based on the reimbursement rate, each bottle of patients need to pay 1000 yuan ~ 1200 yuan, the specific cost is recommended to consult the local regular hospital. This product can inhibit T-cell proliferation and cytokine production, clinically, it is mainly used in the treatment of some classical Hodgkin’s lymphoma, advanced hepatocellular carcinoma, advanced non-small cell lung cancer and other diseases. The frequent adverse reactions of this product include anemia, hypothyroidism, fatigue, reactive capillary hyperplasia, etc. It is contraindicated for those who are allergic to this product. Please purchase under the supervision of a physician and use the drug regularly according to the doctor’s instructions.